Angela Kerins
PharmD, BCPS
Rotations
Internal Medicine (PGY1 and PGY2), Opioid Use Disorder Consult Service Elective
Education
BS Biology: University of Illinois Urbana-Champaign
PharmD: University of Illinois at Chicago
Residency Training
PGY1: University of Chicago Medicine
Practice Interests
General medicine, Opioid Use Disorder, Pain Management, Infectious Disease
Professional Affiliation
AMERSA
Recent Publications
Kerins A, Ito S, Ari M, Murray JP, Weyer G. Overcoming challenges in acute care hospitalizations for patients with opioid use disorder. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):204-211.e2. doi: 10.1016/j.japh.2022.08.004. Epub 2022 Aug 6.
Murray JP, Pucci G, Weyer G, Ari M, Dickson S, Kerins A. Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series. Addict Sci Clin Pract 18, 38 (2023). https://doi.org/10.1186/s13722-023-00392-z
Angela Kerins, Randall Knoebel, David Dickerson, Magdalena Anitescu. Optimizing Institutional Care of Implantable Intrathecal Drug Delivery Systems. International Journal of Anesthesia and Clinical Medicine. Vol. 8, No. 1, 2020, pp. 18-25. doi: 10.11648/j.ijacm.20200801.15
John P Murray, Angela Kerins, Amantadine withdrawal syndrome masquerading as COVID-19 encephalopathy: a case report and review of the literature, Oxford Medical Case Reports, Volume 2021, Issue 2, February 2021, omaa133, https://doi.org/10.1093/omcr/omaa133
Academic and/or National Presentations
Current Research
IDPH grant/initiative OUD acute care and transitions of care management